Diabetic Kidney Disease: Challenges, Progress, and Possibilities.

Diabetic Kidney Disease: Challenges, Progress, and Possibilities.

Item
http://www.wikidata.org/entity/Q40206755
Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy.Tyrosines-740/751 of PDGFRβ contribute to the activation of Akt/Hif1α/TGFβ nexus to drive high glucose-induced glomerular mesangial cell hypertrophy.The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy.Implication of decreased serum complement 3 in patients with diabetic nephropathy.The Warburg Effect in Diabetic Kidney Disease.Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial.Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease.Albumin Overload and PINK1/Parkin Signaling-Related Mitophagy in Renal Tubular Epithelial Cells.Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease.Histone Deacetylase Inhibitors and Diabetic Kidney Disease
P2860

Diabetic Kidney Disease: Challenges, Progress, and Possibilities.

Item
http://www.wikidata.org/entity/Q40206755
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Diabetic Kidney Disease: Challenges, Progress, and Possibilities.
@en
type
label
Diabetic Kidney Disease: Challenges, Progress, and Possibilities.
@en
prefLabel
Diabetic Kidney Disease: Challenges, Progress, and Possibilities.
@en
P1433
P1476
P2093
P2860
P31
P356
P577
P698
P932
P356
P1433
P1476
Diabetic Kidney Disease: Challenges, Progress, and Possibilities.
@en
P2093
P2860
P31
P356
P577
P698
P932